Receiving Helpdesk

which of the following is the most common side effect of tissue plasminogen activator tpa

by Dr. Barbara Kihn Published 3 years ago Updated 2 years ago

What are the side effects of alteplase
alteplase
Alteplase (t-PA) is a thrombolytic medication, used to treat acute ischemic stroke, acute ST-elevation myocardial infarction (a type of heart attack), pulmonary embolism associated with low blood pressure, and blocked central venous catheter. It is given by injection into a vein or artery.
https://en.wikipedia.org › wiki › Alteplase
(TPA, Activase, Cathflo Activase)? The most common and serious side effect of alteplase is bleeding. Minor bleeding is more common, but significant bleeding such as into the brain (intracranial hemorrhage) or fatal bleeding also occurs.

What are the side effects of Alteplase (tpa)?

It also is used for clearing blood clots from blocked venous catheters. What are the side effects of alteplase (TPA, Activase, Cathflo Activase)? The most common and serious side effect of alteplase is bleeding. Minor bleeding is more common, but significant bleeding such as into the brain (intracranial hemorrhage) or fatal bleeding also occurs.

What are the possible side effects of TPA?

Bleeding is the most common side effect of tPA. The patient is closely monitored for bleeding (at IV insertion sites, gums, urine/stools, and intracranially by assessing changes in level of consciousness). Headache, increased ICP, and hypertension are not side effects of tPA.

Can TPA cause intestinal bleeding?

Additionally, TPA can cause stomach bleeding, intestinal bleeding, bleeding in the urine, or bleeding of healing wounds or surgical incisions. For these reasons, some patients are not candidates for TPA. 2

What is tPA (Tissue plasminogen activator)?

Claudia Chaves, MD, is board-certified in cerebrovascular disease and neurology with a subspecialty certification in vascular neurology. Tissue plasminogen activator, most commonly known as TPA, is a powerful blood thinner used for emergency stroke treatment.

What is the effect of tPA?

TPA works by dissolving blood clots. That helps to restore blood flow to the brain after a stroke, potentially preventing additional brain cells from dying.

What is the effect of tissue plasminogen activator tPA in stroke treatment?

Tissue plasminogen Activator (tPA) is used to treat stroke in its early stages. The medication is a protein that activates enzymes to break down blood clots, helping to restore blood flow to the brain during an acute ischemic stroke. IV administration of tPA is the gold-standard treatment for stroke.

What are problems with tPA?

Potential Risk As with most treatments, there are risks associated with tPA administration. Studies vary in predicting the likelihood of complications, which include bleeding into the brain, other types of serious bleeding (e.g., gastrointestinal), and death.

What is a complication of long term tPA?

Complications of TPA Bleeding is a serious complication that can result in a hemorrhagic stroke, which is often more serious than an ischemic stroke. Additionally, TPA can cause stomach bleeding, intestinal bleeding, bleeding in the urine, or bleeding of healing wounds or surgical incisions.

How does tPA cause hemorrhage?

The risk of hemorrhage is increased because tPA triggers plasmin activation, which degrades cross-linked fibrin into fibrin split products and reversal agents. Reperfusion injury and breakdown of the blood-brain barrier may also contribute to the risk of symptomatic intracranial hemorrhage.

What is tPA stroke?

A tPA is a drug used to break up a blood clot and restore blood flow to the brain. A tPA can only be administered within a few hours after stroke symptoms appear, so it is extremely important to call 911 at the first sign of a stroke.

What is the most important toxicity associated with alteplase?

The most common and serious side effect of alteplase is bleeding. Minor bleeding is more common, but significant bleeding such as into the brain (intracranial hemorrhage) or fatal bleeding also occurs. Other important side effects include: Nausea.

When do the majority of bleeding complications occur after tPA administration?

Most SICH hemorrhages will occur within the first 24 hours after receiving IV r-tPA, with the bulk of fatal hemorrhages occurring within the first 12 hours.

Can tPA cause bradycardia?

A retrospective chart review of 41 subjects showed that 80% of subjects experienced dysrhythmias during TPA therapy. The most common dysrhythmia was sinus bradycardia, followed by idioventricular/accelerated idioventricular rhythm, ventricular premature beats, and ventricular tachycardia/fibrillation.

Can tPA cause angioedema?

tPA-associated angioedema is a rare (1.3 – 5.1% incidence), but known complication. One must remain vigilant and be on guard for this. While treating one potentially life-threatening disease, you may induce another. Be ready to manage the airway.

What is tissue plasminogen activator?

Tissue plasminogen activator is a powerful agent that dissolves blood clots. It is injected by intravenous administration (IV) for emergency stroke treatment. A stroke is caused by an interruption in blood flow either due to a blood clot ( ischemic stroke) or a bleed ( hemorrhagic stroke) in the brain. TPA is only used for strokes caused by blood ...

How does TPA work?

When TPA is injected into a vein, it quickly travels through the blood to reach the clogged blood vessel, where it works by trying to dissolve the blood clot and to restore blood flow to the brain.

What is TPA in 2021?

Huma Sheikh, MD. on April 21, 2021. Tissue plasminogen activator, most commonly known as TPA, is a powerful blood thinner used for emergency stroke treatment. Approved 20 years ago for the treatment of stroke, it was initially viewed as both revolutionary and risky. Now, twenty years later, stroke treatment has advanced a lot, ...

How long does it take to use TPA?

Clinical guidelines for the early treatment of stroke published jointly by the American Heart Association and American Stroke Association strongly recommend the use of TPA for eligible patients within three hours of symptom onset. Some of the eligibility criteria involved in the decision to use TPA include ...

Is TPA a blood thinner?

Because TPA is a powerful blood thinner, the main side effect is bleeding. Bleeding is a serious complication that can result in a hemorrhagic stroke, which is often more serious than an ischemic stroke.

Do patients ask for TPA?

Most of the time, patients do not ask for TPA. But emergency medical workers are trained to recognize a stroke and emergency rooms are equipped with the staff and provisions to administer TPA when it is necessary.

Is TPA safe after a stroke?

TPA is an important stroke treatment that can save your life. However, it can be dangerous and not everyone is a safe candidate for TPA. Also, if the narrow time interval has elapsed by the time you reach the hospital, you cannot receive intravenous TPA treatment because it is only beneficial if it is given within the first few hours after a stroke has started.

Which plasminogen activator is the most efficient inhibitor of t-PA?

Inhibitory regulation is provided by the plasminogen activator inhibitor-1 (PAI-1) and the plasmin inhibitor. PAI-1 is the most efficient inhibitor of t-PA in plasma and the majority of circulating t-PA is bound to this inhibitor.

What is the function of plasminogen activator?

Tissue plasminogen activator (tPA, tissue-type plasminogen activator) is a serine protease found on endothelial cells (cells that line the blood vessels) involved in the breakdown of blood clots ( fibrinolysis ). tPA enzyme catalyzes the conversion of plasminogen to plasmin.

What are the methods of measuring t-PA?

These can be divided into specific t-PA assays, and non-specific global tests. Two common methods today are the global, euglobulin clot lysis time and the fibrin plate assay. Specific t-PA assays include immunological methods which measure t-PA antigen (i.e. both free t-PA and t-PA/PAI-1), and functional methods. The latter are either chromogenic assays using chromogenic plasmin substrates and stimulators, or bioimmunoassays that use a combination of monoclonal antibodies and chromogenic plasmin substrates.

What is the primary target of plasminogen?

Plasminogen is the proenzyme of plasmin, whose primary target is the degradation of fibrin in the vasculature. The activation of plasminogen to plasmin in blood is catalyzed by t-PA secreted from endothelial cells. Fibrin provides binding sites for both plasminogen and t-PA, thereby optimizing contact between them.

What is a tPA?

tPA may be manufactured using recombinant biotechnology techniques. tPA created this way may be referred to as recombinant tissue plasminogen activator (rtPA).

What is the function of t-PA?

The major physiological function of t-PA is to generate plasmin that can dissolve blood clots in the vasculature. Recent studies suggest that reduced t-PA activity and elevated t-PA and PAI-1 antigen levels may be a risk marker for cardiovascular disease.

What is the function of plasmin?

Plasmin is involved in a variety of biological processes, including cell migration, growth, inflammation and tumour invasion, although its primary function is assumed to be lysis of fibrin in the vasculature.

What are the side effects of a syringe?

redness of the skin. slow or irregular breathing or heartbeat. sudden loss of consciousness. sweating. swelling of the face, fingers, feet, lower legs, or ankles. unconsciousness. unusual tiredness or weakness. weight gain. Managing side effects (general information)

Does alteplase cause side effects?

Side effects requiring immediate medical attention. Along with its needed effects, alteplase may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. Check with your doctor or nurse immediately if any of the following side effects occur while taking alteplase:

Can alteplase cause bleeding?

Bleeding has been the most frequent side effect noted with alteplase therapy . Arterial punctures are of particular concern and an upper extremity accessible to manual compression is preferred if arterial puncture is required. The usual precautions and procedures following arterial catheterization are extremely important. It is recommended that other invasive procedures be avoided or minimized. Non-compressible venous sites should be avoided. [ Ref]

What causes TIA?

TIAs result from impaired blood circulation in the brain, which can be caused by atherosclerosis and arteriosclerosis, cardiac disease, or diabetes. The symptoms of a TIA are the result of impaired blood circulation in the brain, which may have been caused by cardiac disease.

What are the symptoms of a TIA?

The symptoms of a TIA are the result of impaired blood circulation in the brain, which may have been caused by diabetes. The symptoms of a TIA are the result of impaired blood circulation in the brain, which may have been caused by hypertension.

What happens when you damage your motor neurons?

Damage to the lower motor neurons may cause decreased muscle tone, flaccid muscle paralysis, and a decrease in or loss of reflexes.

What is the nursing management of a patient with global aphasia?

Nursing management of the patient with global aphasia includes speaking clearly to the patient in simple sentences and using gestures or pictures when able. Nursing management of the patient with receptive aphasia includes speaking slowing and clearly to assist the patient in forming the sounds.

What are the side effects of alteplase?

The most common and serious side effect of alteplase is bleeding. Minor bleeding is more common, but significant bleeding such as into the brain (intracranial hemorrhage) or fatal bleeding also occurs. Other important side effects include: Nausea. Vomiting.

How long does Alteplase take to work?

Heart attack: For heart attacks the recommended dose is a 15 mg injection followed by 50 mg or 0.75 mg/kg (up to 50 mg) infused over 30 minutes then 35 mg or 0.5 mg/kg (up to 35 mg) over 60 minutes. The total dose is 100 mg.

What is Alteplase used for?

Alteplase is used to treat persons with heart attacks (acute myocardial infarctions), strokes, chest pain at rest (unstable angina), blood clots in the lungs (pulmonary thrombosis or embolism), and other less common conditions involving blood clots. It also is used for clearing blood clots from blocked venous catheters.

What is the enzyme that causes blood clots to dissolve?

Alteplase is an enzyme that occurs naturally in man and causes blood clots to dissolve. It is a man-made protein manufactured by recombinant DNA technology. The naturally occurring protein, known as tissue plasminogen activator (TPA), is made by ovarian cells from the Chinese hamster.

How to report a drug problem to the FDA?

Report Problems to the Food and Drug Administration. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

When was Alteplase first approved?

When was alteplase (TPA, Activase, Cathflo Activase) approved by the FDA? Alteplase was first approved for heart attacks in 1987. In 1996, it was approved for strokes.

Does Alteplase harm rabbits?

Alteplase has been shown to cause damage to embryos of rabbits. No damage has been reported in humans. Doctors must carefully balance potential risks and possible benefits when prescribing alteplase to pregnant women. It is not known whether alteplase passes into breast milk.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9
8.3.21PHP Version1.74sRequest Duration2MBMemory UsageGET {post}Route
  • warninglog[16:40:24] LOG.warning: Creation of dynamic property Barryvdh\Debugbar\DataFormatter\QueryFormatter:...
  • warninglog[16:40:24] LOG.warning: Creation of dynamic property Barryvdh\Debugbar\DataFormatter\QueryFormatter:...
  • warninglog[16:40:24] LOG.warning: Callables of the form ["Swift_SmtpTransport", "Swift_Transport_EsmtpTranspor...
  • warninglog[16:40:24] LOG.warning: Creation of dynamic property Barryvdh\Debugbar\DataFormatter\SimpleFormatter...
  • warninglog[16:40:24] LOG.warning: Creation of dynamic property Barryvdh\Debugbar\DataFormatter\SimpleFormatter...
  • warninglog[16:40:24] LOG.warning: json_decode(): Passing null to parameter #1 ($json) of type string is deprec...
  • warninglog[16:40:24] LOG.warning: json_decode(): Passing null to parameter #1 ($json) of type string is deprec...
  • warninglog[16:40:24] LOG.warning: json_decode(): Passing null to parameter #1 ($json) of type string is deprec...
  • warninglog[16:40:24] LOG.warning: json_decode(): Passing null to parameter #1 ($json) of type string is deprec...
  • warninglog[16:40:24] LOG.warning: json_decode(): Passing null to parameter #1 ($json) of type string is deprec...
  • warninglog[16:40:24] LOG.warning: json_decode(): Passing null to parameter #1 ($json) of type string is deprec...
  • warninglog[16:40:24] LOG.warning: json_decode(): Passing null to parameter #1 ($json) of type string is deprec...
  • warninglog[16:40:24] LOG.warning: mt_rand(): Passing null to parameter #2 ($max) of type int is deprecated in ...
  • warninglog[16:40:24] LOG.warning: explode(): Passing null to parameter #2 ($string) of type string is deprecat...
  • Booting (27.47ms)
  • Application (1.71s)
  • 1 x Application (98.39%)
    1.71s
    1 x Booting (1.58%)
    27.47ms
    7 templates were rendered
    • themes.DevBlog.content.post (resources/views/themes/DevBlog/content/post.blade.php)34blade
      Params
      0
      post
      1
      postContent
      2
      author
      3
      updated_at
      4
      bing_rich_snippet_text
      5
      bing_rich_snippet_link
      6
      bing_related_keywords
      7
      google_related_keywords
      8
      bing_news_title
      9
      bing_news_description
      10
      bing_videos
      11
      bing_images
      12
      bing_search_result_title
      13
      bing_search_result_description
      14
      bing_search_result_url
      15
      bing_paa_questions
      16
      bing_paa_answers
      17
      bing_slider_faq_questions
      18
      bing_slider_faq_answers
      19
      bing_pop_faq_questions
      20
      bing_pop_faq_answers
      21
      bing_tab_faq_questions
      22
      bing_tab_faq_answers
      23
      google_faq_questions
      24
      google_faq_answers
      25
      google_rich_snippet
      26
      google_search_result
      27
      indexedArray
      28
      total_images
      29
      total_videos
      30
      settings
      31
      url_current
      32
      menus
      33
      sidebar
    • themes.DevBlog.layouts.master (resources/views/themes/DevBlog/layouts/master.blade.php)41blade
      Params
      0
      __env
      1
      app
      2
      errors
      3
      post
      4
      postContent
      5
      author
      6
      updated_at
      7
      bing_rich_snippet_text
      8
      bing_rich_snippet_link
      9
      bing_related_keywords
      10
      google_related_keywords
      11
      bing_news_title
      12
      bing_news_description
      13
      bing_videos
      14
      bing_images
      15
      bing_search_result_title
      16
      bing_search_result_description
      17
      bing_search_result_url
      18
      bing_paa_questions
      19
      bing_paa_answers
      20
      bing_slider_faq_questions
      21
      bing_slider_faq_answers
      22
      bing_pop_faq_questions
      23
      bing_pop_faq_answers
      24
      bing_tab_faq_questions
      25
      bing_tab_faq_answers
      26
      google_faq_questions
      27
      google_faq_answers
      28
      google_rich_snippet
      29
      google_search_result
      30
      indexedArray
      31
      total_images
      32
      total_videos
      33
      settings
      34
      url_current
      35
      menus
      36
      sidebar
      37
      i
      38
      __currentLoopData
      39
      loop
      40
      item
    • themes.DevBlog.panels.head (resources/views/themes/DevBlog/panels/head.blade.php)41blade
      Params
      0
      __env
      1
      app
      2
      errors
      3
      post
      4
      postContent
      5
      author
      6
      updated_at
      7
      bing_rich_snippet_text
      8
      bing_rich_snippet_link
      9
      bing_related_keywords
      10
      google_related_keywords
      11
      bing_news_title
      12
      bing_news_description
      13
      bing_videos
      14
      bing_images
      15
      bing_search_result_title
      16
      bing_search_result_description
      17
      bing_search_result_url
      18
      bing_paa_questions
      19
      bing_paa_answers
      20
      bing_slider_faq_questions
      21
      bing_slider_faq_answers
      22
      bing_pop_faq_questions
      23
      bing_pop_faq_answers
      24
      bing_tab_faq_questions
      25
      bing_tab_faq_answers
      26
      google_faq_questions
      27
      google_faq_answers
      28
      google_rich_snippet
      29
      google_search_result
      30
      indexedArray
      31
      total_images
      32
      total_videos
      33
      settings
      34
      url_current
      35
      menus
      36
      sidebar
      37
      i
      38
      __currentLoopData
      39
      loop
      40
      item
    • themes.DevBlog.panels.header (resources/views/themes/DevBlog/panels/header.blade.php)41blade
      Params
      0
      __env
      1
      app
      2
      errors
      3
      post
      4
      postContent
      5
      author
      6
      updated_at
      7
      bing_rich_snippet_text
      8
      bing_rich_snippet_link
      9
      bing_related_keywords
      10
      google_related_keywords
      11
      bing_news_title
      12
      bing_news_description
      13
      bing_videos
      14
      bing_images
      15
      bing_search_result_title
      16
      bing_search_result_description
      17
      bing_search_result_url
      18
      bing_paa_questions
      19
      bing_paa_answers
      20
      bing_slider_faq_questions
      21
      bing_slider_faq_answers
      22
      bing_pop_faq_questions
      23
      bing_pop_faq_answers
      24
      bing_tab_faq_questions
      25
      bing_tab_faq_answers
      26
      google_faq_questions
      27
      google_faq_answers
      28
      google_rich_snippet
      29
      google_search_result
      30
      indexedArray
      31
      total_images
      32
      total_videos
      33
      settings
      34
      url_current
      35
      menus
      36
      sidebar
      37
      i
      38
      __currentLoopData
      39
      loop
      40
      item
    • themes.DevBlog.panels.navbar (resources/views/themes/DevBlog/panels/navbar.blade.php)41blade
      Params
      0
      __env
      1
      app
      2
      errors
      3
      post
      4
      postContent
      5
      author
      6
      updated_at
      7
      bing_rich_snippet_text
      8
      bing_rich_snippet_link
      9
      bing_related_keywords
      10
      google_related_keywords
      11
      bing_news_title
      12
      bing_news_description
      13
      bing_videos
      14
      bing_images
      15
      bing_search_result_title
      16
      bing_search_result_description
      17
      bing_search_result_url
      18
      bing_paa_questions
      19
      bing_paa_answers
      20
      bing_slider_faq_questions
      21
      bing_slider_faq_answers
      22
      bing_pop_faq_questions
      23
      bing_pop_faq_answers
      24
      bing_tab_faq_questions
      25
      bing_tab_faq_answers
      26
      google_faq_questions
      27
      google_faq_answers
      28
      google_rich_snippet
      29
      google_search_result
      30
      indexedArray
      31
      total_images
      32
      total_videos
      33
      settings
      34
      url_current
      35
      menus
      36
      sidebar
      37
      i
      38
      __currentLoopData
      39
      loop
      40
      item
    • themes.DevBlog.panels.footer (resources/views/themes/DevBlog/panels/footer.blade.php)41blade
      Params
      0
      __env
      1
      app
      2
      errors
      3
      post
      4
      postContent
      5
      author
      6
      updated_at
      7
      bing_rich_snippet_text
      8
      bing_rich_snippet_link
      9
      bing_related_keywords
      10
      google_related_keywords
      11
      bing_news_title
      12
      bing_news_description
      13
      bing_videos
      14
      bing_images
      15
      bing_search_result_title
      16
      bing_search_result_description
      17
      bing_search_result_url
      18
      bing_paa_questions
      19
      bing_paa_answers
      20
      bing_slider_faq_questions
      21
      bing_slider_faq_answers
      22
      bing_pop_faq_questions
      23
      bing_pop_faq_answers
      24
      bing_tab_faq_questions
      25
      bing_tab_faq_answers
      26
      google_faq_questions
      27
      google_faq_answers
      28
      google_rich_snippet
      29
      google_search_result
      30
      indexedArray
      31
      total_images
      32
      total_videos
      33
      settings
      34
      url_current
      35
      menus
      36
      sidebar
      37
      i
      38
      __currentLoopData
      39
      loop
      40
      item
    • themes.DevBlog.panels.scripts (resources/views/themes/DevBlog/panels/scripts.blade.php)41blade
      Params
      0
      __env
      1
      app
      2
      errors
      3
      post
      4
      postContent
      5
      author
      6
      updated_at
      7
      bing_rich_snippet_text
      8
      bing_rich_snippet_link
      9
      bing_related_keywords
      10
      google_related_keywords
      11
      bing_news_title
      12
      bing_news_description
      13
      bing_videos
      14
      bing_images
      15
      bing_search_result_title
      16
      bing_search_result_description
      17
      bing_search_result_url
      18
      bing_paa_questions
      19
      bing_paa_answers
      20
      bing_slider_faq_questions
      21
      bing_slider_faq_answers
      22
      bing_pop_faq_questions
      23
      bing_pop_faq_answers
      24
      bing_tab_faq_questions
      25
      bing_tab_faq_answers
      26
      google_faq_questions
      27
      google_faq_answers
      28
      google_rich_snippet
      29
      google_search_result
      30
      indexedArray
      31
      total_images
      32
      total_videos
      33
      settings
      34
      url_current
      35
      menus
      36
      sidebar
      37
      i
      38
      __currentLoopData
      39
      loop
      40
      item
    uri
    GET {post}
    middleware
    web, checkdate
    as
    post.show
    controller
    App\Http\Controllers\Frontend\json_data\PostController@show
    namespace
    where
    file
    app/Http/Controllers/Frontend/json_data/PostController.php:18-166
    7 statements were executed1.69s
    • select * from `posts` where `published_at` <= '2025-06-14 16:40:24' and `slug` = 'which-of-the-following-is-the-most-common-side-effect-of-tissue-plasminogen-activator-tpa' and `posts`.`deleted_at` is null limit 1
      5.1ms/app/Providers/RouteServiceProvider.php:54receivinghelpdeskask
      Metadata
      Bindings
      • 0. 2025-06-14 16:40:24
      • 1. which-of-the-following-is-the-most-common-side-effect-of-tissue-plasminogen-activator-tpa
      Backtrace
      • 15. /app/Providers/RouteServiceProvider.php:54
      • 18. /vendor/laravel/framework/src/Illuminate/Routing/Router.php:842
      • 19. Route binding:39
      • 20. /vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:167
      • 21. /vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:78
    • select * from `json_post_contents` where `json_post_contents`.`post_id` = 168527 and `json_post_contents`.`post_id` is not null and `rewrite_id` = 0
      10.67msmiddleware::checkdate:30receivinghelpdeskask
      Metadata
      Bindings
      • 0. 168527
      • 1. 0
      Backtrace
      • 19. middleware::checkdate:30
      • 20. /vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:167
      • 21. /vendor/laravel/jetstream/src/Http/Middleware/ShareInertiaData.php:61
      • 22. /vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:167
      • 23. /vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
    • select * from `nova_menu_menus` where `slug` = 'header' limit 1
      380μs/vendor/outl1ne/nova-menu-builder/src/helpers.php:32receivinghelpdeskask
      Metadata
      Bindings
      • 0. header
      Backtrace
      • 15. /vendor/outl1ne/nova-menu-builder/src/helpers.php:32
      • 17. /vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. /vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:45
      • 19. /vendor/laravel/framework/src/Illuminate/Routing/Route.php:261
      • 20. /vendor/laravel/framework/src/Illuminate/Routing/Route.php:205
    • select * from `nova_menu_menu_items` where `nova_menu_menu_items`.`menu_id` = 1 and `nova_menu_menu_items`.`menu_id` is not null and `parent_id` is null order by `parent_id` asc, `order` asc, `name` asc
      260μs/vendor/outl1ne/nova-menu-builder/src/Models/Menu.php:35receivinghelpdeskask
      Metadata
      Bindings
      • 0. 1
      Backtrace
      • 19. /vendor/outl1ne/nova-menu-builder/src/Models/Menu.php:35
      • 20. /vendor/outl1ne/nova-menu-builder/src/helpers.php:33
      • 22. /vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 23. /vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:45
      • 24. /vendor/laravel/framework/src/Illuminate/Routing/Route.php:261
    • select * from `nova_menu_menu_items` where `nova_menu_menu_items`.`parent_id` in (1) order by `order` asc
      190μs/vendor/outl1ne/nova-menu-builder/src/Models/Menu.php:35receivinghelpdeskask
      Metadata
      Backtrace
      • 24. /vendor/outl1ne/nova-menu-builder/src/Models/Menu.php:35
      • 25. /vendor/outl1ne/nova-menu-builder/src/helpers.php:33
      • 27. /vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 28. /vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:45
      • 29. /vendor/laravel/framework/src/Illuminate/Routing/Route.php:261
    • select `id`, `post_title`, `slug` from `posts` where `status` = 'publish' and `posts`.`deleted_at` is null order by RAND() limit 10
      1.67s/app/View/Composers/SidebarView.php:22receivinghelpdeskask
      Metadata
      Bindings
      • 0. publish
      Backtrace
      • 14. /app/View/Composers/SidebarView.php:22
      • 15. /app/View/Composers/SidebarView.php:12
      • 16. /vendor/laravel/framework/src/Illuminate/View/Concerns/ManagesEvents.php:124
      • 17. /vendor/laravel/framework/src/Illuminate/View/Concerns/ManagesEvents.php:162
      • 20. /vendor/laravel/framework/src/Illuminate/View/Concerns/ManagesEvents.php:177
    • select * from `fake_users` where `fake_users`.`id` = 39874 limit 1
      740μsview::2dd102cf0462e89a4d4d8bc77355d767652bf9aa:15receivinghelpdeskask
      Metadata
      Bindings
      • 0. 39874
      Backtrace
      • 21. view::2dd102cf0462e89a4d4d8bc77355d767652bf9aa:15
      • 23. /vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:108
      • 24. /vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 25. /vendor/livewire/livewire/src/ComponentConcerns/RendersLivewireComponents.php:69
      • 26. /vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:61
    App\Models\FakeUser
    1
    Outl1ne\MenuBuilder\Models\MenuItem
    1
    Outl1ne\MenuBuilder\Models\Menu
    1
    App\Models\JsonPostContent
    1
    App\Models\Post
    11
        _token
        EnjxACeslhc5Lp3KaEN6LGS0A2PEnR03u8oVbeIk
        _previous
        array:1 [ "url" => "https://receivinghelpdesk.com/ask/which-of-the-following-is-the-most-common-si...
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /which-of-the-following-is-the-most-common-side-effect-of-tissue-plasminogen-activator-tpa
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:25 [ "cookie" => array:1 [ 0 => "XSRF-TOKEN=eyJpdiI6Im5aaFBHdkRxNnpwejBvV2J6bmlhRlE9PSIsInZhbHVlIjoicXhNbGFlUXlXOE1pR2pqZGx4UWx2VkNtaGVJSE9YWkNEMGRPT25UWDQ1ZHJzZzV0aEdmQm5QZ3hZK0M2VWxHZURlemwwa0ZidXZHRGVjREtOVTVHc25PcXMydTd1WGxUWHlna2Zad3dtbnpQVm1mcm9GM2xnMjgwVGJCNkJOK0UiLCJtYWMiOiJjYTE0MWZkOGJlYzhjYzAwODI5ZmY1N2FiM2M0OTUwNzdhYjlhYWQ2NzZjYjQ4ODg5NDFlNWYzN2EyMDRkNjE4IiwidGFnIjoiIn0%3D; askhelpdesk_session=eyJpdiI6IkZJK1Ayem82U0NQVkZjcmkya3MzZWc9PSIsInZhbHVlIjoiWDYzTmVnZTNZZjJhQXdsVzBISXExN1FqNmwvOFlQYTA0OFp2K0RrdEdRTHpZUjRjRng2R1dHQzlFcDNLM2gxcTl0NndCRjV3NDl1RTJpOWdDa096R1NRYnk3clV5UFBjNjN4VXZPZituaXNWZjhObXRXb2R6ejFSdGlaSm5JSTgiLCJtYWMiOiI5Y2MzYWE2YzZhN2M5N2QxNzFmNTQ0ZDVhNWJmZjgxZTYzNmNkNTZmOWM1ZDcwN2Y1MjRmMDMyYmM5YjEwODBiIiwidGFnIjoiIn0%3D; _pk_id.64.7c30=553050a3bac55781.1749899421.; _pk_ses.64.7c30=1XSRF-TOKEN=eyJpdiI6Im5aaFBHdkRxNnpwejBvV2J6bmlhRlE9PSIsInZhbHVlIjoicXhNbGFlUXlXOE1pR2pqZGx4UWx2VkNtaGVJSE9YWkNEMGRPT25UWDQ1ZHJzZzV0aEdmQm5QZ3hZK0M2VWxHZURlemwwa" ] "cf-ipcountry" => array:1 [ 0 => "US" ] "cf-connecting-ip" => array:1 [ 0 => "216.73.216.243" ] "cdn-loop" => array:1 [ 0 => "cloudflare; loops=1" ] "sec-fetch-mode" => array:1 [ 0 => "navigate" ] "sec-fetch-site" => array:1 [ 0 => "none" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "sec-ch-ua-platform" => array:1 [ 0 => ""Windows"" ] "sec-ch-ua-mobile" => array:1 [ 0 => "?0" ] "sec-ch-ua" => array:1 [ 0 => ""Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "accept-encoding" => array:1 [ 0 => "gzip, br" ] "cf-ray" => array:1 [ 0 => "94f96188ff44e81d-ORD" ] "priority" => array:1 [ 0 => "u=0, i" ] "sec-fetch-dest" => array:1 [ 0 => "document" ] "sec-fetch-user" => array:1 [ 0 => "?1" ] "cf-visitor" => array:1 [ 0 => "{"scheme":"https"}" ] "connection" => array:1 [ 0 => "close" ] "x-forwarded-proto" => array:1 [ 0 => "https" ] "x-forwarded-for" => array:1 [ 0 => "216.73.216.243, 172.71.254.68" ] "x-server-addr" => array:1 [ 0 => "154.12.239.204" ] "host" => array:1 [ 0 => "receivinghelpdesk.com" ] ]
        request_server
        0 of 0
        array:56 [ "USER" => "runcloud" "HOME" => "/home/runcloud" "SCRIPT_NAME" => "/ask/index.php" "REQUEST_URI" => "/ask/which-of-the-following-is-the-most-common-side-effect-of-tissue-plasminogen-activator-tpa" "QUERY_STRING" => "" "REQUEST_METHOD" => "GET" "SERVER_PROTOCOL" => "HTTP/1.0" "GATEWAY_INTERFACE" => "CGI/1.1" "REDIRECT_URL" => "/ask/which-of-the-following-is-the-most-common-side-effect-of-tissue-plasminogen-activator-tpa" "REMOTE_PORT" => "51594" "SCRIPT_FILENAME" => "/home/runcloud/webapps/ReceivingHelpDesk/ask/index.php" "SERVER_ADMIN" => "you@example.com" "CONTEXT_DOCUMENT_ROOT" => "/home/runcloud/webapps/ReceivingHelpDesk/" "CONTEXT_PREFIX" => "" "REQUEST_SCHEME" => "http" "DOCUMENT_ROOT" => "/home/runcloud/webapps/ReceivingHelpDesk/" "REMOTE_ADDR" => "172.71.254.68" "SERVER_PORT" => "80" "SERVER_ADDR" => "127.0.0.1" "SERVER_NAME" => "receivinghelpdesk.com" "SERVER_SOFTWARE" => "Apache/2.4.63 (Unix) OpenSSL/1.1.1f" "SERVER_SIGNATURE" => "" "LD_LIBRARY_PATH" => "/RunCloud/Packages/apache2-rc/lib" "PATH" => "/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin" "HTTP_COOKIE" => "XSRF-TOKEN=eyJpdiI6Im5aaFBHdkRxNnpwejBvV2J6bmlhRlE9PSIsInZhbHVlIjoicXhNbGFlUXlXOE1pR2pqZGx4UWx2VkNtaGVJSE9YWkNEMGRPT25UWDQ1ZHJzZzV0aEdmQm5QZ3hZK0M2VWxHZURlemwwa0ZidXZHRGVjREtOVTVHc25PcXMydTd1WGxUWHlna2Zad3dtbnpQVm1mcm9GM2xnMjgwVGJCNkJOK0UiLCJtYWMiOiJjYTE0MWZkOGJlYzhjYzAwODI5ZmY1N2FiM2M0OTUwNzdhYjlhYWQ2NzZjYjQ4ODg5NDFlNWYzN2EyMDRkNjE4IiwidGFnIjoiIn0%3D; askhelpdesk_session=eyJpdiI6IkZJK1Ayem82U0NQVkZjcmkya3MzZWc9PSIsInZhbHVlIjoiWDYzTmVnZTNZZjJhQXdsVzBISXExN1FqNmwvOFlQYTA0OFp2K0RrdEdRTHpZUjRjRng2R1dHQzlFcDNLM2gxcTl0NndCRjV3NDl1RTJpOWdDa096R1NRYnk3clV5UFBjNjN4VXZPZituaXNWZjhObXRXb2R6ejFSdGlaSm5JSTgiLCJtYWMiOiI5Y2MzYWE2YzZhN2M5N2QxNzFmNTQ0ZDVhNWJmZjgxZTYzNmNkNTZmOWM1ZDcwN2Y1MjRmMDMyYmM5YjEwODBiIiwidGFnIjoiIn0%3D; _pk_id.64.7c30=553050a3bac55781.1749899421.; _pk_ses.64.7c30=1XSRF-TOKEN=eyJpdiI6Im5aaFBHdkRxNnpwejBvV2J6bmlhRlE9PSIsInZhbHVlIjoicXhNbGFlUXlXOE1pR2pqZGx4UWx2VkNtaGVJSE9YWkNEMGRPT25UWDQ1ZHJzZzV0aEdmQm5QZ3hZK0M2VWxHZURlemwwa" "HTTP_CF_IPCOUNTRY" => "US" "HTTP_CF_CONNECTING_IP" => "216.73.216.243" "HTTP_CDN_LOOP" => "cloudflare; loops=1" "HTTP_SEC_FETCH_MODE" => "navigate" "HTTP_SEC_FETCH_SITE" => "none" "HTTP_ACCEPT" => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" "HTTP_USER_AGENT" => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" "HTTP_UPGRADE_INSECURE_REQUESTS" => "1" "HTTP_SEC_CH_UA_PLATFORM" => ""Windows"" "HTTP_SEC_CH_UA_MOBILE" => "?0" "HTTP_SEC_CH_UA" => ""Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"" "HTTP_CACHE_CONTROL" => "no-cache" "HTTP_PRAGMA" => "no-cache" "HTTP_ACCEPT_ENCODING" => "gzip, br" "HTTP_CF_RAY" => "94f96188ff44e81d-ORD" "HTTP_PRIORITY" => "u=0, i" "HTTP_SEC_FETCH_DEST" => "document" "HTTP_SEC_FETCH_USER" => "?1" "HTTP_CF_VISITOR" => "{"scheme":"https"}" "HTTP_CONNECTION" => "close" "HTTP_X_FORWARDED_PROTO" => "https" "HTTP_X_FORWARDED_FOR" => "216.73.216.243, 172.71.254.68" "HTTP_X_SERVER_ADDR" => "154.12.239.204" "HTTP_HOST" => "receivinghelpdesk.com" "HTTPS" => "on" "REDIRECT_STATUS" => "200" "REDIRECT_HTTPS" => "on" "FCGI_ROLE" => "RESPONDER" "PHP_SELF" => "/ask/index.php" "REQUEST_TIME_FLOAT" => 1749899424.1771 "REQUEST_TIME" => 1749899424 ]
        request_cookies
        0 of 0
        array:4 [ "XSRF-TOKEN" => "EnjxACeslhc5Lp3KaEN6LGS0A2PEnR03u8oVbeIk" "askhelpdesk_session" => "YDoBFlgiDJLUlte9FfspeJDE5O3bmIKe9mgwJaQN" "_pk_id_64_7c30" => null "_pk_ses_64_7c30" => null ]
        response_headers
        0 of 0
        array:7 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "private, must-revalidate" ] "date" => array:1 [ 0 => "Sat, 14 Jun 2025 11:10:24 GMT" ] "pragma" => array:1 [ 0 => "no-cache" ] "expires" => array:1 [ 0 => -1 ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6ImlMdm5XbGEvSEY3NUc1L1V3dEU3bEE9PSIsInZhbHVlIjoiUWVoZ05qSys0emoyTDIvZDkwaUFLMVRabjZTWnNrNzhPVmNrWTZtTlFqZ3NXemFhRGE4N1J3NzBRNXJnVXBZZUpJWDl0Q29TbjhDc0pmZUR6ckt5ajYzMFBMZFpjNEp2eUtJalkvK0I3ZkFEZ3Fvcmg4WHlTMzREdWt6TTdramciLCJtYWMiOiJlMWYzZDgyYzE1Y2RmMTE1MWVhMTVlYTE0NDEwOTNkMzBmZTAwNmRjOGUwZjRhOGM3MThmMWY2MWVlZTdjNGE2IiwidGFnIjoiIn0%3D; expires=Sat, 14-Jun-2025 13:10:25 GMT; Max-Age=7200; path=/; samesite=laxXSRF-TOKEN=eyJpdiI6ImlMdm5XbGEvSEY3NUc1L1V3dEU3bEE9PSIsInZhbHVlIjoiUWVoZ05qSys0emoyTDIvZDkwaUFLMVRabjZTWnNrNzhPVmNrWTZtTlFqZ3NXemFhRGE4N1J3NzBRNXJnVXBZZUpJWDl0Q" 1 => "askhelpdesk_session=eyJpdiI6IlFCSUsxRzlTaTlvZEVDdSs3MnIxQXc9PSIsInZhbHVlIjoiZC9hd3pSK1hOWjhzWElINGJHQ09UV1BidHFSeWVxQWFmdG9oR1Vsd3VseVJablhUQzc0NXRCODB5UUhaL2JnUUhtSE8vemlmdnN1bk8wckt1cXpVeE5DNzFzYm15V1NuODF5dzhMdHpLQXNEWGlCc25NNGd4T1BVRmVCM3JtcHIiLCJtYWMiOiIxZDE1ODFlMDAxMzAzOGU3Zjk5ODgyYmNjYTA0MTM1NDYyYjdiMDc0MjBjM2Q4Y2Y4YzRmZWY1MDIxMTZmYmU4IiwidGFnIjoiIn0%3D; expires=Sat, 14-Jun-2025 13:10:25 GMT; Max-Age=7200; path=/; httponly; samesite=laxaskhelpdesk_session=eyJpdiI6IlFCSUsxRzlTaTlvZEVDdSs3MnIxQXc9PSIsInZhbHVlIjoiZC9hd3pSK1hOWjhzWElINGJHQ09UV1BidHFSeWVxQWFmdG9oR1Vsd3VseVJablhUQzc0NXRCODB5UUhaL2Jn" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6ImlMdm5XbGEvSEY3NUc1L1V3dEU3bEE9PSIsInZhbHVlIjoiUWVoZ05qSys0emoyTDIvZDkwaUFLMVRabjZTWnNrNzhPVmNrWTZtTlFqZ3NXemFhRGE4N1J3NzBRNXJnVXBZZUpJWDl0Q29TbjhDc0pmZUR6ckt5ajYzMFBMZFpjNEp2eUtJalkvK0I3ZkFEZ3Fvcmg4WHlTMzREdWt6TTdramciLCJtYWMiOiJlMWYzZDgyYzE1Y2RmMTE1MWVhMTVlYTE0NDEwOTNkMzBmZTAwNmRjOGUwZjRhOGM3MThmMWY2MWVlZTdjNGE2IiwidGFnIjoiIn0%3D; expires=Sat, 14-Jun-2025 13:10:25 GMT; path=/XSRF-TOKEN=eyJpdiI6ImlMdm5XbGEvSEY3NUc1L1V3dEU3bEE9PSIsInZhbHVlIjoiUWVoZ05qSys0emoyTDIvZDkwaUFLMVRabjZTWnNrNzhPVmNrWTZtTlFqZ3NXemFhRGE4N1J3NzBRNXJnVXBZZUpJWDl0Q" 1 => "askhelpdesk_session=eyJpdiI6IlFCSUsxRzlTaTlvZEVDdSs3MnIxQXc9PSIsInZhbHVlIjoiZC9hd3pSK1hOWjhzWElINGJHQ09UV1BidHFSeWVxQWFmdG9oR1Vsd3VseVJablhUQzc0NXRCODB5UUhaL2JnUUhtSE8vemlmdnN1bk8wckt1cXpVeE5DNzFzYm15V1NuODF5dzhMdHpLQXNEWGlCc25NNGd4T1BVRmVCM3JtcHIiLCJtYWMiOiIxZDE1ODFlMDAxMzAzOGU3Zjk5ODgyYmNjYTA0MTM1NDYyYjdiMDc0MjBjM2Q4Y2Y4YzRmZWY1MDIxMTZmYmU4IiwidGFnIjoiIn0%3D; expires=Sat, 14-Jun-2025 13:10:25 GMT; path=/; httponlyaskhelpdesk_session=eyJpdiI6IlFCSUsxRzlTaTlvZEVDdSs3MnIxQXc9PSIsInZhbHVlIjoiZC9hd3pSK1hOWjhzWElINGJHQ09UV1BidHFSeWVxQWFmdG9oR1Vsd3VseVJablhUQzc0NXRCODB5UUhaL2Jn" ] ]
        session_attributes
        0 of 0
        array:4 [ "_token" => "EnjxACeslhc5Lp3KaEN6LGS0A2PEnR03u8oVbeIk" "_previous" => array:1 [ "url" => "https://receivinghelpdesk.com/ask/which-of-the-following-is-the-most-common-side-effect-of-tissue-plasminogen-activator-tpa" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]